Although SMAD7 was conversely regulated in the mean of both the above cohorts, samples with SMAD7 upregulation and others with downregulation were included in each of them reflecting the vast number of other factors relevant for HCC progression and the necessity of an individualized investigation. The gene discussed is SMAD7; the disease is hepatocellular carcinoma.